56 results
424B3
OCUP
Ocuphire Pharma Inc
16 Feb 24
Prospectus supplement
4:31pm
insurance policies are expensive and protect only from some business risk, which leaves us exposed to significant uninsured liabilities;
environmental
424B5
uoewi xzyewm
14 Aug 23
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
w4z9xipw5k xtny1m
11 Aug 23
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
9:27am
424B5
hjyjzw
7 Jun 21
Prospectus supplement for primary offering
4:21pm
8-K/A
EX-10.1
su4xd4t78t8vv12ipsbn
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-10.1
zolacxtue
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
424B5
l1vwmcxbc2m4gurjypyq
11 Mar 21
Prospectus supplement for primary offering
9:19am
8-K
EX-1.1
pvyt0bis6jr198 2o
11 Mar 21
Entry into a Material Definitive Agreement
8:34am
424B4
mtbo0r3u
17 Feb 21
Prospectus supplement with pricing info
7:14am
D
wfpmvv2bb42e34f2 aw
20 Nov 20
$21.15M in equity / options / securities to be acquired, sold $21.15M, 18 investors
3:21pm
8-K
EX-14.1
3zagl3s7x jiuwl4gqn
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
424B3
fu75qoz9
2 Oct 20
Prospectus supplement
9:25am